AGRYLIN

Swiss trademark · 783610 · Word mark · In force

Register entry

Registration number
783610
Application number
03934/2022
Status
In force
Type
Word mark
Filed
Mar 17, 2022
Registered
Jul 5, 2022
Published
Jul 5, 2022
Protected until
Mar 17, 2032
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate zur Behandlung von Blutkrankheiten; antithrombotische Mittel.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 18, 2026

    Agent’s address changed

    Representative
    Wild Schnyder AG, Forchstrasse 30, P.O. Box, 8032 Zürich → Wild Schnyder AG, Giesshübelstrasse 62, 8045 Zürich

    Published in Swissreg on 18.02.2026

  2. Oct 22, 2024

    Holder’s address changed

    Owner
    Takeda Pharmaceuticals U.S.A., Inc., 95 Hayden Avenue, Lexington, Massachusetts 02421, USA → Takeda Pharmaceuticals U.S.A., Inc., 500 Kendall Street, Cambridge, MA 02142, USA

    Published in Swissreg on 22.10.2024

  3. May 4, 2023

    Transferred

    Owner
    Shire International Licensing B.V., Mercuriusplein 11, 5th floor, 2132 HA Hoofddorp, Netherlands → Takeda Pharmaceuticals U.S.A., Inc., 95 Hayden Avenue, Lexington, Massachusetts 02421, USA

    Published in Swissreg on 04.05.2023

  4. Jul 5, 2022

    Registered

    Published in Swissreg on 05.07.2022

Parties

Holder

Takeda Pharmaceuticals U.S.A., Inc.

500 Kendall Street, Cambridge, MA 02142, US

Agent

Wild Schnyder AG

Giesshübelstrasse 62, 8045 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.